Previous studies have shown that blocking VEGFA‐VEGFR2 signalling with soluble VEGFR1 can accelerate the progression of glomerulosclerosis, loss of PTCs, and interstitial fibrosis [50]. This evidence concerns the gene KDR and glomerulosclerosis.